These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 16333108)
1. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. Lewis RE; Wiederhold NP; Lionakis MS; Prince RA; Kontoyiannis DP J Clin Microbiol; 2005 Dec; 43(12):6120-2. PubMed ID: 16333108 [TBL] [Abstract][Full Text] [Related]
2. Gliotoxin production by clinical and environmental Aspergillus fumigatus strains. Kupfahl C; Michalka A; Lass-Flörl C; Fischer G; Haase G; Ruppert T; Geginat G; Hof H Int J Med Microbiol; 2008 Apr; 298(3-4):319-27. PubMed ID: 17574915 [TBL] [Abstract][Full Text] [Related]
3. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. Rüping MJ; Gerlach S; Fischer G; Lass-Flörl C; Hellmich M; Vehreschild JJ; Cornely OA J Hosp Infect; 2011 Jul; 78(3):226-30. PubMed ID: 21440331 [TBL] [Abstract][Full Text] [Related]
4. Investigation of extracellular elastase, acid proteinase and phospholipase activities as putative virulence factors in clinical isolates of Aspergillus species. Alp S; Arikan S J Basic Microbiol; 2008 Oct; 48(5):331-7. PubMed ID: 18759239 [TBL] [Abstract][Full Text] [Related]
5. [Possible sources of aspergilla infection in a hematological hospital]. Petrova NA; Kliasova GA Ter Arkh; 2005; 77(7):71-7. PubMed ID: 16116914 [TBL] [Abstract][Full Text] [Related]
6. Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model. Kupfahl C; Heinekamp T; Geginat G; Ruppert T; Härtl A; Hof H; Brakhage AA Mol Microbiol; 2006 Oct; 62(1):292-302. PubMed ID: 16956378 [TBL] [Abstract][Full Text] [Related]
7. Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Reeves EP; Messina CG; Doyle S; Kavanagh K Mycopathologia; 2004 Jul; 158(1):73-9. PubMed ID: 15487324 [TBL] [Abstract][Full Text] [Related]
8. Influence of media and temperature on gliotoxin production in Aspergillus fumigatus strains. Kosalec I; Pepeljnjak S; Jandrlić M Arh Hig Rada Toksikol; 2005 Sep; 56(3):269-73. PubMed ID: 16180613 [TBL] [Abstract][Full Text] [Related]
9. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Krishnan S; Manavathu EK; Chandrasekar PH Mycoses; 2009 May; 52(3):206-22. PubMed ID: 19207851 [TBL] [Abstract][Full Text] [Related]
10. Effect of aeration on gliotoxin production by Aspergillus fumigatus in its culture filtrate. Watanabe A; Kamei K; Sekine T; Waku M; Nishimura K; Miyaji M; Tatsumi K; Kuriyama T Mycopathologia; 2004 Jan; 157(1):19-27. PubMed ID: 15008341 [TBL] [Abstract][Full Text] [Related]
11. Molecular detection and identification of Aspergillus spp. from clinical samples using real-time PCR. Ramírez M; Castro C; Palomares JC; Torres MJ; Aller AI; Ruiz M; Aznar J; Martín-Mazuelos E Mycoses; 2009 Mar; 52(2):129-34. PubMed ID: 18643921 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of phthioic acid in Aspergillus species. Birch M; Drucker DB; Boote V; Denning DW J Med Vet Mycol; 1997; 35(2):143-5. PubMed ID: 9147275 [TBL] [Abstract][Full Text] [Related]
13. [Aspergillus spp. isolations from respiratory tract samples in Trakya University Hospital]. Gürcan S; Demir M; Altiay G; Tikveşli M; Kiliç H; Otkun M Tuberk Toraks; 2007; 55(2):160-6. PubMed ID: 17602344 [TBL] [Abstract][Full Text] [Related]
14. Gliotoxin effects on fungal growth: mechanisms and exploitation. Carberry S; Molloy E; Hammel S; O'Keeffe G; Jones GW; Kavanagh K; Doyle S Fungal Genet Biol; 2012 Apr; 49(4):302-12. PubMed ID: 22405895 [TBL] [Abstract][Full Text] [Related]
15. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Anaissie EJ; Stratton SL; Dignani MC; Summerbell RC; Rex JH; Monson TP; Spencer T; Kasai M; Francesconi A; Walsh TJ Clin Infect Dis; 2002 Mar; 34(6):780-9. PubMed ID: 11850861 [TBL] [Abstract][Full Text] [Related]
16. Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection. Belkacemi L; Barton RC; Hopwood V; Evans EG Med Mycol; 1999 Aug; 37(4):227-33. PubMed ID: 10421857 [TBL] [Abstract][Full Text] [Related]
17. A new pathogenic species of Aspergillus in the Aspergillus fumigatus series. Kwon-Chung KJ Mycologia; 1975; 67(4):770-9. PubMed ID: 1101054 [No Abstract] [Full Text] [Related]
18. Increased production of gliotoxin is related to the formation of biofilm by Aspergillus fumigatus: an immunological approach. Bugli F; Paroni Sterbini F; Cacaci M; Martini C; Lancellotti S; Stigliano E; Torelli R; Arena V; Caira M; Posteraro P; Sanguinetti M; Posteraro B Pathog Dis; 2014 Apr; 70(3):379-89. PubMed ID: 24623580 [TBL] [Abstract][Full Text] [Related]
19. Multiplex PCR for the discrimination of A. fumigatus, A. flavus, A. niger and A. terreus. Logotheti M; Kotsovili-Tseleni A; Arsenis G; Legakis NI J Microbiol Methods; 2009 Feb; 76(2):209-11. PubMed ID: 18992777 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Kaya AD; Kiraz N Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]